Insider filing · ACAD
James Kihara
PRINCIPAL ACCOUNTING OFFICER
profile →
ACADIA Pharmaceuticals Inc.
ACAD · Healthcare · 12 filings in 24 months
ticker →
James Kihara sold $298K of ACADIA Pharmaceuticals (ACAD)
Executed Jun 26, disclosed Jun 29, 3 days later.
Value, as filed
$298K
11,421 sh × $26.08
Executed
Jun 26
the trade date, as filed
Disclosed
Jun 29
3 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JKJames Kihara (PRINCIPAL ACCOUNTING OFFICER) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in ACADIA Pharmaceuticals Inc. (ACAD). The largest single filing was $298K of ACAD (11,421 sh × $26.08, as filed), executed Jun 26.
The name
ACADHealthcare · ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for neurological an…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by James Kihara in ACAD
ACADSALE
ACADIA Pharmaceuticals Inc.
$114K5,401 sh × $21.18
Exec May 26
Filed May 27 · 5:30 PM ET